平凉胃动态检查-【中云体检】,中云体检,临沧体检手术医院哪家较好,西双版纳常体检都检查什么项目,亳州肠检查做什么,吉安体检医院那好,济南么病会四肢无力,石河子身无力多日
平凉胃动态检查葫芦岛什么突然四肢无力,衡水体好瘦咋办,宝鸡在去医院做全身检查要多少钱啊,衢州体检手术医院哪家较好,南宁北新区体检常识,陇南身检查体检项目,五家渠肠镜检查注意什么
NEW YORK, Dec. 1 (Xinhua) -- New York City Mayor Michael Bloomberg announced on Thursday a new recommendation that doctors offer every person with an HIV diagnosis antiretroviral treatment to help them live longer and prevent transmission.This marks a change from the current practice that treatment only be offered to those who show signs of damage to their immune systems, said the mayor during the annual World AIDS Day commemorative ceremony at Gracie Mansion. "Over the past ten years HIV diagnoses and deaths in New York City have seen a dramatic decline," said Mayor Bloomberg. "Steady progress in our fight against HIV has turned what used to be a death sentence into a disease that can be prevented and, with antiretroviral therapy, managed.The annual death toll from HIV in the city is down by more than a third: 933 deaths in 2009Despite this progress, however, more than 110,000 people in New York City are infected with HIV, more than in any other U.S. city and about 75 percent of all cases in the New York State.Figures from the New York City Health and Hospitals Corporation (HHC) showed that HHC has tested more than one million New Yorkers for HIV since 2005 when the public hospitals and health centers began offering HIV screening as a routine part of medical care for patients aged 13 to 64.
BEIJING, Nov. 22 (Xinhuanet) -- Underweight patients may have more possibilities of mortality within 30 days of general and vascular surgery compared with mildly obese patients, according to a research published online in Archives of Surgery Tuesday.Researchers at the U.S. National Surgical Quality Improvement Program conducted the research for the years 2005 and 2006, and assessed the contribution of BMI (Body Mass Index) to 189,533 postsurgeries morbidity and mortality by obesity classes.They found that compared with the middle BMI quintile group, patients with BMI value below 23.1, had greater chances for death. For the highest BMI quintile group, higher mortality rate was also observed.However, the researchers also found that obesity may as well be associated with increased mortality for some individual types of surgeries."These individual types of procedures include procedures with which the general surgeon should have definite experience: colorectal resection, colostomy formation, cholecystectomy, hernia repair, mastectomy, and wound debridement," said George J. Stukenborg, PhD, of the University of Virginia inCharlottesvilleand his colleagues.Based on a 30 –day morbidity and mortality risk calculation, the sample patients were categorized into BMI quintile ranges. BMI value of less than 23.1 was considered as lowest, values from 26.3 to 29.6 considered as the middle quintile, and above 35.2 considered as the highest.Factors such as lack of enough data on nonfatal complications and hospital resources, or examining mortality over the 30-day baseline, may cause limitations and inaccuracy to the research and more studies on a wider range of patients in terms of BMI are needed to further confirm the current conclusion, researchers said.
BEIJING, Sept. 30 (Xinhuanet) -- Tobacco companies concealed the knowledge of radioactive substance in cigarettes from public for over four decades, a new study revealed.The revelation was made by a research team from the University of California, Los Angeles, published on Thursday in the online edition of the U.S. medical journal Nicotine and Tobacco Research.The researchers analyzed 27 timeworn documents and discovered that tobacco companies had knew the existence of polonium-210, a hazardous radioactive substance, in the tobacco since 1959.The companies studied polonium-210 throughout the 1960s, and concealed their findings about the carcinogenic potential of the radioactive substance.Hrayr Karagueuzian, the study's lead author, said the tobacco companies' deception surprised him.According to the revelation, the companies had knew the "cancerous growths" in the lungs of smokers, and even calculated how much radiation a regular smoker would inhale over 20 years.Karagueuzian and his team conducted again the study recorded in the tobacco documents and found that the radiation in cigarettes would cause up to 138 deaths for every 1,000 smokers over a period of 25 years.However, tobacco manufacturer denied that they had concealed the facts from the public.David Sutton, spokesman of Philip Morris, the largest U.S. tobacco company, said the polonium-210 was a "naturally occurring element in the air" and had been widely discussed by the public health community for years.
BERLIN, Jan. 17 (Xinhua) -- Researchers in Germany have found a cheap and easy way to synthesize anti-malaria drug in large quantities from waste materials, said the Max Planck Society on Tuesday.Currently there are nearly one million people die worldwide each year due to lack of effective drugs, as sweet wormwood, from which artemisinin, the effective essence to fight malaria can be extracted, only grows in China, Vietnam and a few other countries.However, researchers in Germany have now developed a simple process for the synthesis of artemisinin in laboratory, using artemisinic acid, a substance contained in the by-product, or waste materials of the isolation of artemisinin from sweet wormwoods, as row materials of synthesizing artemisinin."The production of the drug is therefore no longer dependent on obtaining the active ingredient from plants," said Peter Seeberger, director at the Max Planck Institute of Colloids and Interfaces in Potsdam and professor at Free University of Berlin.The artemisinic acid in the waste material boasts a volume 10 times greater than the active ingredient itself, said Seeberger, and they could be turned into artemisinin in four and a half minutes in a so-called continuous-flow reactor.Seeberger estimated that 800 of the reactors would be enough to cover the global requirement for artemisinin, and the whole innovative synthesis process could be ready for technical use in three to six months.Malaria is a disease caused by parasites that are transmitted to people through the bites of infected mosquitoes. In 2010, malaria caused an estimated 655,000 deaths, mostly among African children.
BEIJING, Oct. 7 (Xinhua) -- Chinese scientists are developing new methods like spraying or dropping hepatitis vaccines into people's noses to replace traditional injections, according to a leading expert on immunology.Such researches were sponsored by a key national science project, according to Wen Yumei, an academician of the Chinese Academy of Engineering, also the chairwoman of the 14th International Symposium on Viral Hepatitis and Liver Disease, which is scheduled to be held in Shanghai next July.At a press conference held here Friday for the symposium, experts believed that broad-coverage inoculations is an effective way in facilitating the country's goal in controlling Hepatitis B.China's Ministry of Health has also credited its national immunization program for having protected about 80 million people from being infected with the Hepatitis B virus (HBV) in the 19 years after 1992.Recent report showed that about 93 million Chinese are HBV carriers, accounting for more than a quarter of the world's total.